PMC8429022_01
Results of retrospective 6-day continuous glucose monitoring (CGM) system (iPro 2 system, Medtronic MiniMed, Northridge, CA, USA) in the second year (November 2017) following diagnosis revealed normal glucose levels.
CRIE2021-3511281.001.jpg
PMC8429022_01_CRIE2021-3511281.001.jpg
fig1
Medtronic MiniMed, Northridge, CA, USA) in the second year following diagnosis confirmed normoglycemia as shown in Figure 1. MMST was firstly evaluated at the second year after diagnosis to assess the reserved beta-cell function.
Clinical course and sequential laboratory data in this patient.
CRIE2021-3511281.002.jpg
PMC8429022_01_CRIE2021-3511281.002.jpg
fig2
A1C was maintained between 5.0 and 6.2% without any antidiabetic medication for more than 5 years as shown in Figure 2.